Castle Biosciences Inc. (CSTL) Tops Q4 EPS by 22c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. ANT
4. FFAI
5. FFR
6. LLY
7. TSLA
8. META
9. FICO
10. CART

Go back to Castle Biosciences Inc. (CSTL) Tops Q4 EPS by 22c

Castle Biosciences Reports Fourth Quarter and Full-Year 2021 Results

February 28, 2022 4:05 PM EST

Full-year 2021 revenue was up 50% over 2020 to $94.1 million, beating expectations
Growth of 55% year over year in total GEP testing volume
Full-year 2022 revenue is expected to be between $115-120 million
Conference call and webcast today at 4:30 p.m. ET

FRIENDSWOOD, Texas--(BUSINESS WIRE)-- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results for the fourth quarter and twelve months ended Dec. 31, 2021.

Driven by our patient-centric focus and our commitment to strong execution on our... More